Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising c. difficile-associated disease rates

Infection Control and Hospital Epidemiology

Volumn 35, Issue 6, 2014, Pages 667-673

  Koo, Hoonmo L ^a,b,c   Van, John N ^a   Zhao, Meina ^a   Ye, Xunyan ^a   Revell, Paula A ^d   Jiang, Zhi Dong ^b   Grimes, Carolyn Z ^b   Koo, Diana C ^b   Lasco, Todd ^c   Kozinetz, Claudia A ^a   Garey, Kevin W ^b,c,e   DuPont, Herbert L ^a,b,c,f  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c St Luke's Hospital   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

^e UNIVERSITY OF HOUSTON   (United States)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIAL COLONIZATION; CLOSTRIDIUM DIFFICILE INFECTION; CYTOTOXICITY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; FEMALE; HEALTH CARE FACILITY; HUMAN; INFECTION CONTROL PRACTITIONER; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; MORBIDITY; REAL TIME POLYMERASE CHAIN REACTION; UNIVERSITY HOSPITAL; AGED; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GENETICS; HEALTH SURVEY; ISOLATION AND PURIFICATION; PEPTOCLOSTRIDIUM DIFFICILE; REPRODUCIBILITY; STANDARDS;

ADULT; AGED; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS;

EID: 84899812464     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/676433     Document Type: Article

References (33)

1. McDonald LC, Owings M, Jernigan DB. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006;12:409-415.
2. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007;13:1417-1419.
3. Musher DM, Aslam S, Logan N, et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005;40:1586-1590.
4. O'Horo JC, Jones A, Sternke M, Harper C, Safdar N. Molecular techniques for diagnosis of Clostridium difficile infection: systematic review and meta-analysis. Mayo Clin Proc 2012;87:643-651.
5. Schutze GE, Willoughby RE. Clostridium difficile infection in infants and children. Pediatrics 2013;131:196-200.
6. American Society for Microbiology (ASM). A Practical Guidance Document for the Laboratory Detection of Toxigenic Clostridium difficile. Washington, DC: ASM, September 21, 2010. http://www.asm.org/images/pdf/Clinical/clostridiumdifficile9-21.pdf. Accessed September 19, 2013.
7. Centers for Disease Control and Prevention. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012;61:157-162.
8. Catanzaro M, Cirone J. Real-time polymerase chain reaction testing for Clostridium difficile reduces isolation time and improves patient management in a small community hospital. Am J Infect Control 2012;40:663-666.
9. Luna RA, Boyanton BL Jr, Mehta S, et al. Rapid stool-based diagnosis of Clostridium difficile infection by real-time PCR in a children's hospital. J Clin Microbiol 2011;49:851-857.
10. Fong KS, Fatica C, Hall G, et al. Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level? Infect Control Hosp Epidemiol 2011;32(9):932-933.
11. Longtin Y, Trottier S, Brochu G, et al. Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 2013;56:67-73.
12. Gould CV, Edwards JR, Cohen J, et al. Effect of nucleic acid amplification testing on population-based incidence rates of Clostridium difficile infection. Clin Infect Dis 2013;57:1304-1307.
13. Kvach EJ, Ferguson D, Riska PF, Landry ML. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 2010;48:109-114.
14. Borriello SP, Honour P. Simplified procedure for the routine isolation of Clostridium difficile from faeces. J Clin Pathol 1981; 34:1124-1127.
15. Rosner B. Fundamentals of Biostatistics. 5th ed. Boston: Brooks/-Cole, 2000.
16. Box GEP, Tiao GC. Intervention analysis with applications to economic and environmental problems. J Am Stat Assoc 1975;. 70:70-79.
17. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis 2012;55:216-223.
18. Bartlett JG. Clinical practice: antibiotic-associated diarrhea. N EnglJ Med 2002;346:334-339.
19. Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342:390-397.
20. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N EnglJMed 1989; 320:204-210.
21. Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA, Melvin ZA, Karchmer AW. Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 1994;18:181-187.
22. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007;45:992-998.
23. Tenover FC, Novak-Weekley S, Woods CW, et al. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J Clin Microbiol 2010;48:3719-3724.
24. Planche TD, Davies KA, Coen PG, et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 2013;13:936-945.
25. Berg AM, Kelly CP, Farraye FA. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis 2013;19:194-204.
26. Koo HL, Ajami NJ, Jiang ZD, et al. A nosocomial outbreak of norovirus infection masquerading as Clostridium difficile infection. Clin Infect Dis 2009;48:e75-e77.
27. Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ES-CMID): data review and recommendations for diagnosing Clos-tridium difficile-infection (CDI). Clin Microbiol Infect 2009;15: 1053-1066.
28. Deshpande A, Pasupuleti V, Rolston DD, et al. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis. Clin Infect Dis 2013;53:e81-e90.
29. Wilcox MH. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection. Clin Microbiol Infect 2012;18(suppl 6):13-20.
30. Brecher SM, Novak-Weekley SM, Nagy E. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis 2013;57:1175-1181.
31. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-455.
32. Louie TJ, Emery J, Krulicki W, Byrne B, Mah M. OPT-80 eliminates Clostridium difficile and is sparing of bacteroides species during treatment of C. difficile infection. Antimicrob Agents Che-mother 2009;53:261-263.
33. Garey KW, Graham G, Gerard L, et al. Prevalence of diarrhea at a university hospital and association with modifiable risk factors. Ann Pharmacother 2006;40:1030-1034.